Rates of anomalous bupropion prescriptions in Ontario, Canada

Annals of Family Medicine

Volumn 13, Issue 4, 2015, Pages 343-346

  Steele, Leah S ^a,b,c,d   Macdonald, Erin M ^a   Gomes, Tara ^a,d,e,f   Hollands, Simon ^a   Paterson, J Michael ^a,e,g   Mamdani, Muhammad M ^a,b,d,e,f   Juurlink, David N ^a,e,f,h  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

^h Canada   (Canada)

Author keywords

Bupropion; Drug abuse; Prescription drug diversion

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; SERTRALINE;

CROSS-SECTIONAL STUDY; DRUG MISUSE; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; MALE; ONTARIO; PHARMACY; STATISTICS AND NUMERICAL DATA;

ANTIDEPRESSIVE AGENTS; BUPROPION; CITALOPRAM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; ONTARIO; PHARMACIES; PRESCRIPTION DRUG MISUSE; SERTRALINE;

EID: 84937944808     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1818     Document Type: Article

References (18)

1. Griffith JD, Carranza J, Griffith C, Miller LL. Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry. 1983;44(5 Pt 2):206-208.
2. Miller L, Griffith J. A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers. Psychopharmacology (Berl). 1983;80(3):199-205.
3. McCormick J. Recreational bupropion abuse in a teenager. Br J Clin Pharmacol. 2002;53(2):214.
4. Phillips D. Wellbutrin: misuse and abuse by incarcerated individuals. J Addict Nurs. 2012;23(1):65-69.
5. Hilliard WT, Barloon L, Farley P, Penn JV, Koranek A. Bupropion diversion and misuse in the correctional facility. J Correct Health Care. 2013;19(3):211-217.
6. Yoon G, Westermeyer J. Intranasal bupropion abuse: case report. Am J Addict. 2013;22(2):180.
7. Reeves RR, Ladner ME. Additional evidence of the abuse potential of bupropion. J Clin Psychopharmacol. 2013;33(4):584-585.
8. Khurshid KA, Decker DH. Bupropion insufflation in a teenager. J Child Adolesc Psychopharmacol. 2004;14(1):157-158.
9. Baribeau D, Araki KF. Intravenous bupropion: a previously undocumented method of abuse of a commonly prescribed antidepressant agent. J Addict Med. 2013;7(3):216-217.
10. Kim D, Steinhart B. Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. CJEM. 2010;12(2):158-161.
11. Hill S, Sikand H, Lee J. A case report of seizure induced by bupropion nasal insufflation. Prim Care Companion J Clin Psychiatry. 2007; 9(1):67-69.
12. Interim Chief Coroner's Alert to Ontario Physicians and Pharmacists. Office of the Chief Coroner [letter]. May 7, 2013. http://www.cfpc. ca/uploadedFiles/Publications/_PDFs/130507%20Alert%20to%20 Ontario%20Physicians%20and%20Pharmacists%20re%20Bupropion. pdf. Accessed Mar 31, 2014.
13. Goel V, Williams J, Anderson G, Blackstein-Hirsch P, Fooks C, Naylor D. Patterns of Health Care in Ontario. 2nd Edition ed. Ottawa: Canadian Medical Association; 1996.
14. Biro SC, Barber DT, Kotecha JA. Trends in the use of electronic medical records. Can Fam Physician. 2012;58(1):e21.
15. Glazier RH, Zagorski BM, Rayner J. Comparison of primary care models in Ontario by demographics, case mix and emergency department use, 2008/09 to 2009/10, ICES investigative report, Toronto: Institute for Clinical Evaluative Sciences; 2012.
16. Gosden T, Forland F, Kristiansen IS, et al. Impact of payment method on behaviour of primary care physicians: a systematic review. J Health Serv Res Policy. 2001;6(1):44-55.
17. Federal Drug Administration. FDA drug safety communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide). http://www.fda.gov/Drugs/DrugSafety/ ucm269086.htm. Accessed May 4, 2014.
18. Ontario Ministry of Health and Long-Term Care. 2011/12 Report Card-Ontario Drug Benefit Program. 2012. http://www.health. gov.on.ca/en/public/programs/drugs/publications/opdp/docs/odb_ report_11.pdf. Accessed Apr 5, 2014.